Therapy with substance

Novamind is building the infrastructure required for a regulated psychedelics industry

Why psychedelics?

“Psychedelics, used responsibly and with proper caution, would be for psychiatry what the microscope is for biology or the telescope is for astronomy.”

— Stanislav Grof, MD

Our focus

Empowering healing

We are developing the infrastructure required for a regulated psychedelics industry.

Clinical care

Ketamine-assisted psychotherapy & other innovative therapies

Retreat network

Legal, medically supervised psychedelic experiences

Research

Clinical research for psychedelic medicines

Our network

Global access to psychedelic medicines

  • Novamind is growing a network of specialized psychedelic clinics and retreats

  • Treatment is provided by blending evidence-based principles with psychedelic medicines

  • We guide individuals through their entire healing journey, both at home and abroad

  • Our approach

    Psychedelic therapy - right here, right now

    Novamind enables safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites.

    We provide ketamine-assisted psychotherapy and other novel treatments through our network of Cedar Psychiatry clinics and operate Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine.

    Through our retreat partners, we offer additional access to psychedelics in jurisdictions with established regulations for the use of these alternative medicines.

    Our healthcare divisions

    Our retreat partners

    Our retreat partners